BioCryst Pharmaceuticals, Inc. (BCRX)

8.69 +0.06 (+0.70%) USD  |  NASDAQ  |  Mar 03, 16:00
8.735 +0.04 (+0.52%) After-Hours: 07:58
More

BioCryst Pharmaceuticals Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade
Lantheus Holdings, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade